Complications of Endocrine Surgery: Data From the United HealthSystem Consortium
This trial is active, not recruiting.
|Conditions||thyroid disease, parathyroid disease, endocrine gland|
|Sponsor||University of Arkansas|
|Start date||January 2010|
|End date||December 2017|
|Trial size||1000 participants|
|Trial identifier||NCT01539499, 112685|
The goal of this study is to help better determine the complication rates for endocrine surgery across the nation for both benign and malignant disease. It is our hypothesis that the complication rates are low overall and that malignant disease results in a higher complication rate than benign disease. This study will do a database review from all University HealthSystem Consortium (UHC).
Complication Rates for Endocrine Surgery
time frame: baseline
Male or female participants from 18 years up to 90 years old.
Inclusion Criteria: - All patients between the ages of 18 and 90 years who have a diagnosis of benign multinodular goiter and/or malignant thyroid disease and have undergone a total thyroidectomy as a primary procedure. - Parathyroid patients will also be studied. Exclusion Criteria: - Non endocrine surgery patients
|Official title||Complications of Endocrine Surgery: Data From the United Health System Consortium|
|Principal investigator||Brendan Stack, MD|
Call for more information